Effects of CS-1 on A431 cell proliferation, cell cycle, and epidermal growth factor receptor signal transduction

CS-1, a new alkaloid with a molecular formula of C21H2oOsN2S, is extracted from traditional Chinese medi- cine. Previous studies have shown that CS-1 can inhibit the proliferation of several human carcinoma cells in vivo and in vitro. The aims of this study are to investigate the anti-tumor effect a...

Full description

Saved in:
Bibliographic Details
Published inActa biochimica et biophysica Sinica Vol. 44; no. 2; pp. 136 - 146
Main Authors Du, Haiyan, Xu, Bo, Wu, Caixia, Li, Min, Ran, Fuxiang, Cai, Shaoqing, Cui, Jingrong
Format Journal Article
LanguageEnglish
Published China Oxford University Press 01.02.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:CS-1, a new alkaloid with a molecular formula of C21H2oOsN2S, is extracted from traditional Chinese medi- cine. Previous studies have shown that CS-1 can inhibit the proliferation of several human carcinoma cells in vivo and in vitro. The aims of this study are to investigate the anti-tumor effect and mechanism of CS-1 in epidermal growth factor receptor (EGFR) signaling pathway in human A431 cell line. Through the sulforhodamine B assay, we found that CS-1 inhibited A431 cell prolifer- ation in the concentration- and time-dependent manners. The inhibitory rate ranged from 14.5% to 87.8% after 24 h of incubation. High content screening (HCS) multi- parameters cytotoxicity analysis showed that CS-1 at high concentration had slight cytotoxicity that resulted from the cell permeabilization and slight reduction in total mitochondrial mass, whereas no change in nucleus size/ morphology and lysosomal mass-pH was found. The cyto- toxicity of CS-1 was not a major reason for its anti- proliferative effect. Cell cycle analysis indicated that CS-1 induced Gl-phase arrest in A431 cells in a time- dependent manner at high concentration (2.5 ttM), and S-phase arrest at low concentration (0.625 ttM). The HCS assay also showed that CS-1 could inhibit the EGFR in- ternalization, extracellular-signal-regulated kinase (Erk)/ mitogen-activated protein kinase translocation to nucleus, the accumulation of phosphorylated protein kinase B (Akt), signal transducer and activator of transcription 3 (STAT3), and cyclin D1 in the nucleus. These results were confirmed by the western blot analysis. CS-I might inhibit the epidermal growth factor binding to its recep- tor, resulting in the inhibition of the accumulation of phosphorylated Erk and Akt, and STAT3 in the nucleus, and affecting the transcription of cyclin D1 and cell cycle arrest in G1/S phase.
Bibliography:31-1940/Q
CS-1, a new alkaloid with a molecular formula of C21H2oOsN2S, is extracted from traditional Chinese medi- cine. Previous studies have shown that CS-1 can inhibit the proliferation of several human carcinoma cells in vivo and in vitro. The aims of this study are to investigate the anti-tumor effect and mechanism of CS-1 in epidermal growth factor receptor (EGFR) signaling pathway in human A431 cell line. Through the sulforhodamine B assay, we found that CS-1 inhibited A431 cell prolifer- ation in the concentration- and time-dependent manners. The inhibitory rate ranged from 14.5% to 87.8% after 24 h of incubation. High content screening (HCS) multi- parameters cytotoxicity analysis showed that CS-1 at high concentration had slight cytotoxicity that resulted from the cell permeabilization and slight reduction in total mitochondrial mass, whereas no change in nucleus size/ morphology and lysosomal mass-pH was found. The cyto- toxicity of CS-1 was not a major reason for its anti- proliferative effect. Cell cycle analysis indicated that CS-1 induced Gl-phase arrest in A431 cells in a time- dependent manner at high concentration (2.5 ttM), and S-phase arrest at low concentration (0.625 ttM). The HCS assay also showed that CS-1 could inhibit the EGFR in- ternalization, extracellular-signal-regulated kinase (Erk)/ mitogen-activated protein kinase translocation to nucleus, the accumulation of phosphorylated protein kinase B (Akt), signal transducer and activator of transcription 3 (STAT3), and cyclin D1 in the nucleus. These results were confirmed by the western blot analysis. CS-I might inhibit the epidermal growth factor binding to its recep- tor, resulting in the inhibition of the accumulation of phosphorylated Erk and Akt, and STAT3 in the nucleus, and affecting the transcription of cyclin D1 and cell cycle arrest in G1/S phase.
CS-1; cell cycle; EGFR signaling pathway;high content screening
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1672-9145
1745-7270
DOI:10.1093/abbs/gmr111